[211]
Claim 4 has already been construed to include levofloxacin hemihydrate. In the application under the Regulations in T-2l4-03, Justice Mosley specifically rejected the argument that "the S(-) optical isomer of ofloxacin in a substantially pure form -- means water cannot exist in the compound form", and found that levofloxacin hemihydrate would infringe claims 2 and 17. (
Novopharm
, above at paras. 127-128.)